HivemapperShort
The Honey asset is exhibiting bearish weakness
The Hivemapper asset (HONEY) is expressing bearish behavior and shows that it has the opportunity to fall further. It has attained bad performance in the last month, and three months span by -28.16%, and -44.39%, implying a stable downward direction.
The Honey crypto asset is demonstrating bearishness and downward momentum as it sinks below major trend 20-day and 50-day EMA band's, subject to the sellers' surge it could deteriorate more.
The Honey asset is exhibiting bearish weakness as MACD is below zero line and the RSI is below 50 median line at 41.49, implying that the Hivemapper asset is still in a negative territory and can sink further down.
At press time, the CMP is at $0.1061 with an intraday gain of 1.14% and dominated by the bears on the daily chart. Therefore, the price stands near the critical level of $0.090 support, if it fails to sustain and drops more, price could hit more lower depths.
However, if the price spikes from the current level due to increase in buyers interest, then it could reclaim the taret levels of $0.1500, and $0.1750.
The Honey crypto asset is demonstrating bearishness and downward momentum as it sinks below major trend 20-day and 50-day EMA band's, subject to the sellers' surge it could deteriorate more.
The Honey asset is exhibiting bearish weakness as MACD is below zero line and the RSI is below 50 median line at 41.49, implying that the Hivemapper asset is still in a negative territory and can sink further down.
At press time, the CMP is at $0.1061 with an intraday gain of 1.14% and dominated by the bears on the daily chart. Therefore, the price stands near the critical level of $0.090 support, if it fails to sustain and drops more, price could hit more lower depths.
However, if the price spikes from the current level due to increase in buyers interest, then it could reclaim the taret levels of $0.1500, and $0.1750.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.